nodes	percent_of_prediction	percent_of_DWPC	metapath
Lercanidipine—CYP3A4—Temozolomide—skin cancer	0.106	0.165	CbGbCtD
Lercanidipine—CYP3A4—Imiquimod—skin cancer	0.106	0.165	CbGbCtD
Lercanidipine—CYP2D6—Vemurafenib—skin cancer	0.0912	0.142	CbGbCtD
Lercanidipine—CYP3A4—Vismodegib—skin cancer	0.0733	0.114	CbGbCtD
Lercanidipine—CYP3A7-CYP3A51P—Docetaxel—skin cancer	0.068	0.106	CbGbCtD
Lercanidipine—CYP3A7—Docetaxel—skin cancer	0.068	0.106	CbGbCtD
Lercanidipine—CYP3A4—Vemurafenib—skin cancer	0.058	0.0904	CbGbCtD
Lercanidipine—CYP3A5—Docetaxel—skin cancer	0.051	0.0796	CbGbCtD
Lercanidipine—CYP3A4—Docetaxel—skin cancer	0.0199	0.031	CbGbCtD
Lercanidipine—Cardiac failure—Docetaxel—skin cancer	0.000649	0.00181	CcSEcCtD
Lercanidipine—Pruritus—Vemurafenib—skin cancer	0.000648	0.00181	CcSEcCtD
Lercanidipine—Connective tissue disorder—Temozolomide—skin cancer	0.000648	0.0018	CcSEcCtD
Lercanidipine—Urethral disorder—Temozolomide—skin cancer	0.000646	0.0018	CcSEcCtD
Lercanidipine—Alopecia—Dactinomycin—skin cancer	0.000644	0.00179	CcSEcCtD
Lercanidipine—Feeling abnormal—Imiquimod—skin cancer	0.000644	0.00179	CcSEcCtD
Lercanidipine—Gastrointestinal pain—Imiquimod—skin cancer	0.000639	0.00178	CcSEcCtD
Lercanidipine—Hyponatraemia—Docetaxel—skin cancer	0.000636	0.00177	CcSEcCtD
Lercanidipine—Erythema—Dactinomycin—skin cancer	0.000634	0.00177	CcSEcCtD
Lercanidipine—Agranulocytosis—Fluorouracil—skin cancer	0.000631	0.00176	CcSEcCtD
Lercanidipine—Ill-defined disorder—Bleomycin—skin cancer	0.000631	0.00176	CcSEcCtD
Lercanidipine—Anaemia—Bleomycin—skin cancer	0.000629	0.00175	CcSEcCtD
Lercanidipine—Diarrhoea—Vemurafenib—skin cancer	0.000627	0.00175	CcSEcCtD
Lercanidipine—Migraine—Docetaxel—skin cancer	0.000623	0.00174	CcSEcCtD
Lercanidipine—Erythema multiforme—Temozolomide—skin cancer	0.000623	0.00174	CcSEcCtD
Lercanidipine—Urticaria—Imiquimod—skin cancer	0.000621	0.00173	CcSEcCtD
Lercanidipine—Abdominal pain—Imiquimod—skin cancer	0.000618	0.00172	CcSEcCtD
Lercanidipine—Body temperature increased—Imiquimod—skin cancer	0.000618	0.00172	CcSEcCtD
Lercanidipine—Eye disorder—Temozolomide—skin cancer	0.000616	0.00172	CcSEcCtD
Lercanidipine—Tinnitus—Temozolomide—skin cancer	0.000614	0.00171	CcSEcCtD
Lercanidipine—Malaise—Bleomycin—skin cancer	0.000613	0.00171	CcSEcCtD
Lercanidipine—Cardiac disorder—Temozolomide—skin cancer	0.000612	0.0017	CcSEcCtD
Lercanidipine—Flushing—Temozolomide—skin cancer	0.000612	0.0017	CcSEcCtD
Lercanidipine—Rhinitis—Fluorouracil—skin cancer	0.000609	0.0017	CcSEcCtD
Lercanidipine—Dizziness—Vemurafenib—skin cancer	0.000606	0.00169	CcSEcCtD
Lercanidipine—Angiopathy—Temozolomide—skin cancer	0.000598	0.00167	CcSEcCtD
Lercanidipine—Immune system disorder—Temozolomide—skin cancer	0.000595	0.00166	CcSEcCtD
Lercanidipine—Mediastinal disorder—Temozolomide—skin cancer	0.000594	0.00165	CcSEcCtD
Lercanidipine—Cough—Bleomycin—skin cancer	0.000593	0.00165	CcSEcCtD
Lercanidipine—Ill-defined disorder—Dactinomycin—skin cancer	0.000588	0.00164	CcSEcCtD
Lercanidipine—Anaemia—Dactinomycin—skin cancer	0.000586	0.00163	CcSEcCtD
Lercanidipine—Vomiting—Vemurafenib—skin cancer	0.000582	0.00162	CcSEcCtD
Lercanidipine—Alopecia—Temozolomide—skin cancer	0.000582	0.00162	CcSEcCtD
Lercanidipine—Chest pain—Bleomycin—skin cancer	0.000579	0.00161	CcSEcCtD
Lercanidipine—Myalgia—Bleomycin—skin cancer	0.000579	0.00161	CcSEcCtD
Lercanidipine—Orthostatic hypotension—Docetaxel—skin cancer	0.000579	0.00161	CcSEcCtD
Lercanidipine—Abdominal pain upper—Docetaxel—skin cancer	0.000579	0.00161	CcSEcCtD
Lercanidipine—Rash—Vemurafenib—skin cancer	0.000578	0.00161	CcSEcCtD
Lercanidipine—Mental disorder—Temozolomide—skin cancer	0.000577	0.00161	CcSEcCtD
Lercanidipine—Dermatitis—Vemurafenib—skin cancer	0.000577	0.00161	CcSEcCtD
Lercanidipine—Hypersensitivity—Imiquimod—skin cancer	0.000576	0.0016	CcSEcCtD
Lercanidipine—Headache—Vemurafenib—skin cancer	0.000574	0.0016	CcSEcCtD
Lercanidipine—Malnutrition—Temozolomide—skin cancer	0.000574	0.0016	CcSEcCtD
Lercanidipine—Erythema—Temozolomide—skin cancer	0.000574	0.0016	CcSEcCtD
Lercanidipine—Breast disorder—Docetaxel—skin cancer	0.000572	0.00159	CcSEcCtD
Lercanidipine—Discomfort—Bleomycin—skin cancer	0.000572	0.00159	CcSEcCtD
Lercanidipine—Malaise—Dactinomycin—skin cancer	0.000572	0.00159	CcSEcCtD
Lercanidipine—Cramp muscle—Docetaxel—skin cancer	0.00057	0.00159	CcSEcCtD
Lercanidipine—Aspartate aminotransferase increased—Docetaxel—skin cancer	0.00057	0.00159	CcSEcCtD
Lercanidipine—Toxic epidermal necrolysis—Docetaxel—skin cancer	0.00057	0.00159	CcSEcCtD
Lercanidipine—Nasopharyngitis—Docetaxel—skin cancer	0.000566	0.00158	CcSEcCtD
Lercanidipine—Dysgeusia—Temozolomide—skin cancer	0.000562	0.00156	CcSEcCtD
Lercanidipine—Asthenia—Imiquimod—skin cancer	0.00056	0.00156	CcSEcCtD
Lercanidipine—Confusional state—Bleomycin—skin cancer	0.00056	0.00156	CcSEcCtD
Lercanidipine—Alanine aminotransferase increased—Docetaxel—skin cancer	0.000559	0.00156	CcSEcCtD
Lercanidipine—Pruritus—Imiquimod—skin cancer	0.000553	0.00154	CcSEcCtD
Lercanidipine—Nausea—Vemurafenib—skin cancer	0.000544	0.00152	CcSEcCtD
Lercanidipine—Thrombocytopenia—Bleomycin—skin cancer	0.000543	0.00151	CcSEcCtD
Lercanidipine—Vision blurred—Temozolomide—skin cancer	0.000541	0.00151	CcSEcCtD
Lercanidipine—Myalgia—Dactinomycin—skin cancer	0.00054	0.0015	CcSEcCtD
Lercanidipine—Bronchospasm—Docetaxel—skin cancer	0.000539	0.0015	CcSEcCtD
Lercanidipine—Alopecia—Fluorouracil—skin cancer	0.000536	0.00149	CcSEcCtD
Lercanidipine—Diarrhoea—Imiquimod—skin cancer	0.000535	0.00149	CcSEcCtD
Lercanidipine—Discomfort—Dactinomycin—skin cancer	0.000533	0.00149	CcSEcCtD
Lercanidipine—Angina pectoris—Docetaxel—skin cancer	0.000533	0.00149	CcSEcCtD
Lercanidipine—Ill-defined disorder—Temozolomide—skin cancer	0.000532	0.00148	CcSEcCtD
Lercanidipine—Anaemia—Temozolomide—skin cancer	0.00053	0.00148	CcSEcCtD
Lercanidipine—Anorexia—Bleomycin—skin cancer	0.000529	0.00147	CcSEcCtD
Lercanidipine—Erythema—Fluorouracil—skin cancer	0.000529	0.00147	CcSEcCtD
Lercanidipine—Angioedema—Temozolomide—skin cancer	0.000524	0.00146	CcSEcCtD
Lercanidipine—Pancytopenia—Docetaxel—skin cancer	0.00052	0.00145	CcSEcCtD
Lercanidipine—Hypotension—Bleomycin—skin cancer	0.000519	0.00144	CcSEcCtD
Lercanidipine—Malaise—Temozolomide—skin cancer	0.000517	0.00144	CcSEcCtD
Lercanidipine—Dizziness—Imiquimod—skin cancer	0.000517	0.00144	CcSEcCtD
Lercanidipine—Vertigo—Temozolomide—skin cancer	0.000515	0.00144	CcSEcCtD
Lercanidipine—Neutropenia—Docetaxel—skin cancer	0.000512	0.00143	CcSEcCtD
Lercanidipine—Palpitations—Temozolomide—skin cancer	0.000507	0.00141	CcSEcCtD
Lercanidipine—Thrombocytopenia—Dactinomycin—skin cancer	0.000507	0.00141	CcSEcCtD
Lercanidipine—Musculoskeletal discomfort—Bleomycin—skin cancer	0.000506	0.00141	CcSEcCtD
Lercanidipine—Cough—Temozolomide—skin cancer	0.000501	0.00139	CcSEcCtD
Lercanidipine—Paraesthesia—Bleomycin—skin cancer	0.000498	0.00139	CcSEcCtD
Lercanidipine—Vision blurred—Fluorouracil—skin cancer	0.000498	0.00139	CcSEcCtD
Lercanidipine—Vomiting—Imiquimod—skin cancer	0.000497	0.00138	CcSEcCtD
Lercanidipine—Dyspnoea—Bleomycin—skin cancer	0.000495	0.00138	CcSEcCtD
Lercanidipine—Anorexia—Dactinomycin—skin cancer	0.000493	0.00137	CcSEcCtD
Lercanidipine—Rash—Imiquimod—skin cancer	0.000493	0.00137	CcSEcCtD
Lercanidipine—Dermatitis—Imiquimod—skin cancer	0.000492	0.00137	CcSEcCtD
Lercanidipine—Headache—Imiquimod—skin cancer	0.000489	0.00136	CcSEcCtD
Lercanidipine—Anaemia—Fluorouracil—skin cancer	0.000488	0.00136	CcSEcCtD
Lercanidipine—Arthralgia—Temozolomide—skin cancer	0.000488	0.00136	CcSEcCtD
Lercanidipine—Myalgia—Temozolomide—skin cancer	0.000488	0.00136	CcSEcCtD
Lercanidipine—Anxiety—Temozolomide—skin cancer	0.000487	0.00136	CcSEcCtD
Lercanidipine—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—skin cancer	0.000485	0.00135	CcSEcCtD
Lercanidipine—Stevens-Johnson syndrome—Docetaxel—skin cancer	0.000484	0.00135	CcSEcCtD
Lercanidipine—Discomfort—Temozolomide—skin cancer	0.000482	0.00134	CcSEcCtD
Lercanidipine—Decreased appetite—Bleomycin—skin cancer	0.000482	0.00134	CcSEcCtD
Lercanidipine—Acute coronary syndrome—Docetaxel—skin cancer	0.000481	0.00134	CcSEcCtD
Lercanidipine—Renal failure—Docetaxel—skin cancer	0.00048	0.00134	CcSEcCtD
Lercanidipine—Myocardial infarction—Docetaxel—skin cancer	0.000478	0.00133	CcSEcCtD
Lercanidipine—Neuropathy peripheral—Docetaxel—skin cancer	0.000478	0.00133	CcSEcCtD
Lercanidipine—Dry mouth—Temozolomide—skin cancer	0.000478	0.00133	CcSEcCtD
Lercanidipine—Jaundice—Docetaxel—skin cancer	0.000476	0.00133	CcSEcCtD
Lercanidipine—Stomatitis—Docetaxel—skin cancer	0.000476	0.00133	CcSEcCtD
Lercanidipine—Confusional state—Temozolomide—skin cancer	0.000472	0.00131	CcSEcCtD
Lercanidipine—Musculoskeletal discomfort—Dactinomycin—skin cancer	0.000472	0.00131	CcSEcCtD
Lercanidipine—Nausea—Imiquimod—skin cancer	0.000464	0.00129	CcSEcCtD
Lercanidipine—Hepatobiliary disease—Docetaxel—skin cancer	0.000462	0.00129	CcSEcCtD
Lercanidipine—Nervous system disorder—Temozolomide—skin cancer	0.000459	0.00128	CcSEcCtD
Lercanidipine—Thrombocytopenia—Temozolomide—skin cancer	0.000458	0.00128	CcSEcCtD
Lercanidipine—Feeling abnormal—Bleomycin—skin cancer	0.000457	0.00127	CcSEcCtD
Lercanidipine—Agranulocytosis—Docetaxel—skin cancer	0.000456	0.00127	CcSEcCtD
Lercanidipine—Skin disorder—Temozolomide—skin cancer	0.000455	0.00127	CcSEcCtD
Lercanidipine—Hyperhidrosis—Temozolomide—skin cancer	0.000453	0.00126	CcSEcCtD
Lercanidipine—Chest pain—Fluorouracil—skin cancer	0.00045	0.00125	CcSEcCtD
Lercanidipine—Myalgia—Fluorouracil—skin cancer	0.00045	0.00125	CcSEcCtD
Lercanidipine—Decreased appetite—Dactinomycin—skin cancer	0.00045	0.00125	CcSEcCtD
Lercanidipine—Fatigue—Dactinomycin—skin cancer	0.000446	0.00124	CcSEcCtD
Lercanidipine—Anorexia—Temozolomide—skin cancer	0.000446	0.00124	CcSEcCtD
Lercanidipine—Discomfort—Fluorouracil—skin cancer	0.000445	0.00124	CcSEcCtD
Lercanidipine—Urticaria—Bleomycin—skin cancer	0.000441	0.00123	CcSEcCtD
Lercanidipine—Rhinitis—Docetaxel—skin cancer	0.000439	0.00122	CcSEcCtD
Lercanidipine—Body temperature increased—Bleomycin—skin cancer	0.000439	0.00122	CcSEcCtD
Lercanidipine—Hepatitis—Docetaxel—skin cancer	0.000438	0.00122	CcSEcCtD
Lercanidipine—Confusional state—Fluorouracil—skin cancer	0.000435	0.00121	CcSEcCtD
Lercanidipine—Urinary tract disorder—Docetaxel—skin cancer	0.000433	0.00121	CcSEcCtD
Lercanidipine—Oedema peripheral—Docetaxel—skin cancer	0.000432	0.0012	CcSEcCtD
Lercanidipine—Connective tissue disorder—Docetaxel—skin cancer	0.000431	0.0012	CcSEcCtD
Lercanidipine—Urethral disorder—Docetaxel—skin cancer	0.00043	0.0012	CcSEcCtD
Lercanidipine—Feeling abnormal—Dactinomycin—skin cancer	0.000427	0.00119	CcSEcCtD
Lercanidipine—Musculoskeletal discomfort—Temozolomide—skin cancer	0.000427	0.00119	CcSEcCtD
Lercanidipine—Insomnia—Temozolomide—skin cancer	0.000423	0.00118	CcSEcCtD
Lercanidipine—Gastrointestinal pain—Dactinomycin—skin cancer	0.000423	0.00118	CcSEcCtD
Lercanidipine—Nervous system disorder—Fluorouracil—skin cancer	0.000423	0.00118	CcSEcCtD
Lercanidipine—Thrombocytopenia—Fluorouracil—skin cancer	0.000422	0.00118	CcSEcCtD
Lercanidipine—Tachycardia—Fluorouracil—skin cancer	0.000421	0.00117	CcSEcCtD
Lercanidipine—Paraesthesia—Temozolomide—skin cancer	0.00042	0.00117	CcSEcCtD
Lercanidipine—Dyspnoea—Temozolomide—skin cancer	0.000417	0.00116	CcSEcCtD
Lercanidipine—Somnolence—Temozolomide—skin cancer	0.000416	0.00116	CcSEcCtD
Lercanidipine—Erythema multiforme—Docetaxel—skin cancer	0.000414	0.00115	CcSEcCtD
Lercanidipine—Dyspepsia—Temozolomide—skin cancer	0.000412	0.00115	CcSEcCtD
Lercanidipine—Anorexia—Fluorouracil—skin cancer	0.000411	0.00115	CcSEcCtD
Lercanidipine—Eye disorder—Docetaxel—skin cancer	0.00041	0.00114	CcSEcCtD
Lercanidipine—Abdominal pain—Dactinomycin—skin cancer	0.000409	0.00114	CcSEcCtD
Lercanidipine—Body temperature increased—Dactinomycin—skin cancer	0.000409	0.00114	CcSEcCtD
Lercanidipine—Hypersensitivity—Bleomycin—skin cancer	0.000409	0.00114	CcSEcCtD
Lercanidipine—Decreased appetite—Temozolomide—skin cancer	0.000407	0.00113	CcSEcCtD
Lercanidipine—Cardiac disorder—Docetaxel—skin cancer	0.000407	0.00113	CcSEcCtD
Lercanidipine—Flushing—Docetaxel—skin cancer	0.000407	0.00113	CcSEcCtD
Lercanidipine—Gastrointestinal disorder—Temozolomide—skin cancer	0.000404	0.00113	CcSEcCtD
Lercanidipine—Fatigue—Temozolomide—skin cancer	0.000404	0.00112	CcSEcCtD
Lercanidipine—Hypotension—Fluorouracil—skin cancer	0.000403	0.00112	CcSEcCtD
Lercanidipine—Constipation—Temozolomide—skin cancer	0.0004	0.00112	CcSEcCtD
Lercanidipine—Asthenia—Bleomycin—skin cancer	0.000398	0.00111	CcSEcCtD
Lercanidipine—Angiopathy—Docetaxel—skin cancer	0.000398	0.00111	CcSEcCtD
Lercanidipine—Immune system disorder—Docetaxel—skin cancer	0.000396	0.0011	CcSEcCtD
Lercanidipine—Mediastinal disorder—Docetaxel—skin cancer	0.000395	0.0011	CcSEcCtD
Lercanidipine—Musculoskeletal discomfort—Fluorouracil—skin cancer	0.000393	0.00109	CcSEcCtD
Lercanidipine—Pruritus—Bleomycin—skin cancer	0.000393	0.00109	CcSEcCtD
Lercanidipine—Insomnia—Fluorouracil—skin cancer	0.00039	0.00109	CcSEcCtD
Lercanidipine—Paraesthesia—Fluorouracil—skin cancer	0.000387	0.00108	CcSEcCtD
Lercanidipine—Alopecia—Docetaxel—skin cancer	0.000387	0.00108	CcSEcCtD
Lercanidipine—Feeling abnormal—Temozolomide—skin cancer	0.000386	0.00107	CcSEcCtD
Lercanidipine—Dyspnoea—Fluorouracil—skin cancer	0.000385	0.00107	CcSEcCtD
Lercanidipine—Mental disorder—Docetaxel—skin cancer	0.000384	0.00107	CcSEcCtD
Lercanidipine—Somnolence—Fluorouracil—skin cancer	0.000383	0.00107	CcSEcCtD
Lercanidipine—Gastrointestinal pain—Temozolomide—skin cancer	0.000383	0.00107	CcSEcCtD
Lercanidipine—Malnutrition—Docetaxel—skin cancer	0.000381	0.00106	CcSEcCtD
Lercanidipine—Erythema—Docetaxel—skin cancer	0.000381	0.00106	CcSEcCtD
Lercanidipine—Hypersensitivity—Dactinomycin—skin cancer	0.000381	0.00106	CcSEcCtD
Lercanidipine—Dyspepsia—Fluorouracil—skin cancer	0.00038	0.00106	CcSEcCtD
Lercanidipine—Decreased appetite—Fluorouracil—skin cancer	0.000375	0.00104	CcSEcCtD
Lercanidipine—Dysgeusia—Docetaxel—skin cancer	0.000374	0.00104	CcSEcCtD
Lercanidipine—Gastrointestinal disorder—Fluorouracil—skin cancer	0.000372	0.00104	CcSEcCtD
Lercanidipine—Urticaria—Temozolomide—skin cancer	0.000372	0.00104	CcSEcCtD
Lercanidipine—Asthenia—Dactinomycin—skin cancer	0.000371	0.00103	CcSEcCtD
Lercanidipine—Abdominal pain—Temozolomide—skin cancer	0.00037	0.00103	CcSEcCtD
Lercanidipine—Body temperature increased—Temozolomide—skin cancer	0.00037	0.00103	CcSEcCtD
Lercanidipine—Muscle spasms—Docetaxel—skin cancer	0.000367	0.00102	CcSEcCtD
Lercanidipine—Feeling abnormal—Fluorouracil—skin cancer	0.000355	0.00099	CcSEcCtD
Lercanidipine—Diarrhoea—Dactinomycin—skin cancer	0.000354	0.000987	CcSEcCtD
Lercanidipine—Vomiting—Bleomycin—skin cancer	0.000353	0.000983	CcSEcCtD
Lercanidipine—Anaemia—Docetaxel—skin cancer	0.000353	0.000982	CcSEcCtD
Lercanidipine—Rash—Bleomycin—skin cancer	0.00035	0.000975	CcSEcCtD
Lercanidipine—Dermatitis—Bleomycin—skin cancer	0.00035	0.000974	CcSEcCtD
Lercanidipine—Hypersensitivity—Temozolomide—skin cancer	0.000345	0.000961	CcSEcCtD
Lercanidipine—Urticaria—Fluorouracil—skin cancer	0.000343	0.000955	CcSEcCtD
Lercanidipine—Syncope—Docetaxel—skin cancer	0.000342	0.000953	CcSEcCtD
Lercanidipine—Body temperature increased—Fluorouracil—skin cancer	0.000341	0.00095	CcSEcCtD
Lercanidipine—Palpitations—Docetaxel—skin cancer	0.000337	0.000939	CcSEcCtD
Lercanidipine—Asthenia—Temozolomide—skin cancer	0.000336	0.000936	CcSEcCtD
Lercanidipine—Loss of consciousness—Docetaxel—skin cancer	0.000335	0.000934	CcSEcCtD
Lercanidipine—Cough—Docetaxel—skin cancer	0.000333	0.000927	CcSEcCtD
Lercanidipine—Pruritus—Temozolomide—skin cancer	0.000331	0.000923	CcSEcCtD
Lercanidipine—Nausea—Bleomycin—skin cancer	0.00033	0.000918	CcSEcCtD
Lercanidipine—Vomiting—Dactinomycin—skin cancer	0.000329	0.000917	CcSEcCtD
Lercanidipine—Rash—Dactinomycin—skin cancer	0.000326	0.000909	CcSEcCtD
Lercanidipine—Myalgia—Docetaxel—skin cancer	0.000325	0.000905	CcSEcCtD
Lercanidipine—Arthralgia—Docetaxel—skin cancer	0.000325	0.000905	CcSEcCtD
Lercanidipine—Chest pain—Docetaxel—skin cancer	0.000325	0.000905	CcSEcCtD
Lercanidipine—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—skin cancer	0.000323	0.000898	CcSEcCtD
Lercanidipine—Diarrhoea—Temozolomide—skin cancer	0.00032	0.000892	CcSEcCtD
Lercanidipine—Hypersensitivity—Fluorouracil—skin cancer	0.000318	0.000885	CcSEcCtD
Lercanidipine—Dry mouth—Docetaxel—skin cancer	0.000318	0.000885	CcSEcCtD
Lercanidipine—Confusional state—Docetaxel—skin cancer	0.000314	0.000874	CcSEcCtD
Lercanidipine—Dizziness—Temozolomide—skin cancer	0.00031	0.000862	CcSEcCtD
Lercanidipine—Nausea—Dactinomycin—skin cancer	0.000307	0.000856	CcSEcCtD
Lercanidipine—Shock—Docetaxel—skin cancer	0.000306	0.000853	CcSEcCtD
Lercanidipine—Nervous system disorder—Docetaxel—skin cancer	0.000305	0.00085	CcSEcCtD
Lercanidipine—Pruritus—Fluorouracil—skin cancer	0.000305	0.00085	CcSEcCtD
Lercanidipine—Thrombocytopenia—Docetaxel—skin cancer	0.000305	0.000849	CcSEcCtD
Lercanidipine—Tachycardia—Docetaxel—skin cancer	0.000304	0.000846	CcSEcCtD
Lercanidipine—Skin disorder—Docetaxel—skin cancer	0.000302	0.000842	CcSEcCtD
Lercanidipine—Vomiting—Temozolomide—skin cancer	0.000298	0.000829	CcSEcCtD
Lercanidipine—Anorexia—Docetaxel—skin cancer	0.000297	0.000827	CcSEcCtD
Lercanidipine—Rash—Temozolomide—skin cancer	0.000295	0.000822	CcSEcCtD
Lercanidipine—Diarrhoea—Fluorouracil—skin cancer	0.000295	0.000822	CcSEcCtD
Lercanidipine—Dermatitis—Temozolomide—skin cancer	0.000295	0.000821	CcSEcCtD
Lercanidipine—Headache—Temozolomide—skin cancer	0.000293	0.000817	CcSEcCtD
Lercanidipine—Hypotension—Docetaxel—skin cancer	0.000291	0.00081	CcSEcCtD
Lercanidipine—Dizziness—Fluorouracil—skin cancer	0.000285	0.000795	CcSEcCtD
Lercanidipine—Musculoskeletal discomfort—Docetaxel—skin cancer	0.000284	0.00079	CcSEcCtD
Lercanidipine—Insomnia—Docetaxel—skin cancer	0.000282	0.000784	CcSEcCtD
Lercanidipine—Paraesthesia—Docetaxel—skin cancer	0.00028	0.000779	CcSEcCtD
Lercanidipine—Nausea—Temozolomide—skin cancer	0.000278	0.000775	CcSEcCtD
Lercanidipine—Dyspnoea—Docetaxel—skin cancer	0.000278	0.000773	CcSEcCtD
Lercanidipine—Somnolence—Docetaxel—skin cancer	0.000277	0.000771	CcSEcCtD
Lercanidipine—Vomiting—Fluorouracil—skin cancer	0.000274	0.000764	CcSEcCtD
Lercanidipine—Dyspepsia—Docetaxel—skin cancer	0.000274	0.000763	CcSEcCtD
Lercanidipine—Rash—Fluorouracil—skin cancer	0.000272	0.000758	CcSEcCtD
Lercanidipine—Dermatitis—Fluorouracil—skin cancer	0.000272	0.000757	CcSEcCtD
Lercanidipine—Decreased appetite—Docetaxel—skin cancer	0.000271	0.000754	CcSEcCtD
Lercanidipine—Headache—Fluorouracil—skin cancer	0.00027	0.000753	CcSEcCtD
Lercanidipine—Gastrointestinal disorder—Docetaxel—skin cancer	0.000269	0.000749	CcSEcCtD
Lercanidipine—Fatigue—Docetaxel—skin cancer	0.000268	0.000748	CcSEcCtD
Lercanidipine—Constipation—Docetaxel—skin cancer	0.000266	0.000742	CcSEcCtD
Lercanidipine—Feeling abnormal—Docetaxel—skin cancer	0.000257	0.000715	CcSEcCtD
Lercanidipine—Nausea—Fluorouracil—skin cancer	0.000256	0.000714	CcSEcCtD
Lercanidipine—Gastrointestinal pain—Docetaxel—skin cancer	0.000255	0.000709	CcSEcCtD
Lercanidipine—Abdominal pain—Docetaxel—skin cancer	0.000246	0.000686	CcSEcCtD
Lercanidipine—Body temperature increased—Docetaxel—skin cancer	0.000246	0.000686	CcSEcCtD
Lercanidipine—Hypersensitivity—Docetaxel—skin cancer	0.000229	0.000639	CcSEcCtD
Lercanidipine—Asthenia—Docetaxel—skin cancer	0.000223	0.000622	CcSEcCtD
Lercanidipine—Pruritus—Docetaxel—skin cancer	0.00022	0.000614	CcSEcCtD
Lercanidipine—Diarrhoea—Docetaxel—skin cancer	0.000213	0.000593	CcSEcCtD
Lercanidipine—Dizziness—Docetaxel—skin cancer	0.000206	0.000573	CcSEcCtD
Lercanidipine—Vomiting—Docetaxel—skin cancer	0.000198	0.000551	CcSEcCtD
Lercanidipine—Rash—Docetaxel—skin cancer	0.000196	0.000547	CcSEcCtD
Lercanidipine—Dermatitis—Docetaxel—skin cancer	0.000196	0.000546	CcSEcCtD
Lercanidipine—Headache—Docetaxel—skin cancer	0.000195	0.000543	CcSEcCtD
Lercanidipine—Nausea—Docetaxel—skin cancer	0.000185	0.000515	CcSEcCtD
